HSP

LAKE FOREST, Ill., Jan. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE:HSP), a leading global hospital products company, today announced that Christopher B. Begley, chief executive officer, Hospira, will make a formal presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City on Wednesday, Feb. 7, 2007, at 10:20 a.m. Eastern Time. The presentation will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site, http://www.hospirainvestor.com/. Listeners should log on approximately 10 minutes before the presentation start time to ensure proper computer setup for accessing the audiocast. In addition, the slides accompanying the presentation will be available on the Hospira Web site at 10 a.m. Eastern Time on Feb. 7, 2007. A replay will be available on the Hospira Web site approximately 24 hours after the live presentation until Feb. 21. About Hospira Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the productivity, safety and efficacy of patient care. With 70 years of service to the hospital industry, Hospira's portfolio includes one of the industry's broadest lines of generic acute-care injectables, which help address the high cost of proprietary pharmaceuticals; integrated solutions for medication management and infusion therapy; and the leading U.S. injectable contract manufacturing business. Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately 13,000 employees and 14 manufacturing facilities worldwide. Hospira's news releases and other information can be found at http://www.hospira.com/. http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT: Media, Stacey Eisen, +1-224-212-2276, or Financial Community, Lynn McHugh, +1-224-212-2363, both of Hospira, Inc. Web site: http://www.hospira.com/

Copyright